Simone Mocellin
Biographic Data
| ID | 9993268 |
|---|---|
| NAME | Simone Mocellin |
| GIVEN NAMES | Simone |
| FAMILY NAME | Mocellin |
| SIGNATURE | MOCELLIN S |
| AFFILIATIONS | University of Padua |
| ORCID | 0000-0002-9433-8445 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Healthcare costs of cutaneous melanoma according to comorbidity patterns
Background: Cutaneous malignant melanoma represents a notable public health issue, characterized by a rapidly increasing incidence, particularly among younger populations. Despite progress in early detection and treatment modalities, this rising trend exacerbates the healthcare system's burden. Limited research has been conducted on the impact of comorbidities on overall and melanoma-specific healthcare costs incurred by patients with melanoma. T…
Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019
Background: This observational study considers the sex-specific incidence of the most incident cancers as recorded in the population-based Veneto Regional Cancer Registry over a period of more than 30 years (1987-2019). Methods: The Veneto Regional Cancer Registry collected data for the time interval 1987-2019. Significant changes in incidence trends calculated on age-standardized incidence rates (Annual Percent Change-APC) were identified by joi…
Synchronous and metachronous multiple primary cancers in melanoma survivors
Background: Long-term survivors of cutaneous malignant melanoma (CMM) risk subsequent malignancies due to both host-related and environmental risk factors. This retrospective population-based study differentially assesses the risk of synchronous and metachronous cancers in a cohort of CMM survivors stratified by sex. Methods: The cohort study (1999-2018) included 9,726 CMM survivors (M = 4,873, F = 4,853) recorded by the cancer registry of all 5,…
Impact of Wide Local Excision on Melanoma Patient Survival
Introduction Promoting standardization and quality assurance (QA) in oncology on the strength of real-world data is essential to ensure better patient outcomes. Wide excision after primary tumor biopsy is a fundamental step in the therapeutic pathway for cutaneous malignant melanoma (CMM). The aim of this population-based cohort study is to assess adherence to wide local excision in a cohort of patients diagnosed with CMM and the impact of this r…
No prominent works on this page.
Impact of Wide Local Excision on Melanoma Patient Survival
Introduction Promoting standardization and quality assurance (QA) in oncology on the strength of real-world data is essential to ensure better patient outcomes. Wide excision after primary tumor biopsy is a fundamental step in the therapeutic pathway for cutaneous malignant melanoma (CMM). The aim of this population-based cohort study is to assess adherence to wide local excision in a cohort of patients diagnosed with CMM and the impact of this r…
Synchronous and metachronous multiple primary cancers in melanoma survivors
Background: Long-term survivors of cutaneous malignant melanoma (CMM) risk subsequent malignancies due to both host-related and environmental risk factors. This retrospective population-based study differentially assesses the risk of synchronous and metachronous cancers in a cohort of CMM survivors stratified by sex. Methods: The cohort study (1999-2018) included 9,726 CMM survivors (M = 4,873, F = 4,853) recorded by the cancer registry of all 5,…
Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019
Background: This observational study considers the sex-specific incidence of the most incident cancers as recorded in the population-based Veneto Regional Cancer Registry over a period of more than 30 years (1987-2019). Methods: The Veneto Regional Cancer Registry collected data for the time interval 1987-2019. Significant changes in incidence trends calculated on age-standardized incidence rates (Annual Percent Change-APC) were identified by joi…
Healthcare costs of cutaneous melanoma according to comorbidity patterns
Background: Cutaneous malignant melanoma represents a notable public health issue, characterized by a rapidly increasing incidence, particularly among younger populations. Despite progress in early detection and treatment modalities, this rising trend exacerbates the healthcare system's burden. Limited research has been conducted on the impact of comorbidities on overall and melanoma-specific healthcare costs incurred by patients with melanoma. T…
Cancer (4 works) · Cancer registry (3 works) · Cutaneous Melanoma Detection and Management (3 works) · Internal Medicine (3 works) · Medicine (3 works) · Cohort (2 works) · Multiple and Secondary Primary Cancers (2 works) · Oncology (2 works) · Population (2 works) · Cancer Immunotherapy and Biomarkers (1 work)